Opus Genetics CEO George Magrath Sells 9,511 Shares

What Happened George Magrath, CEO of Opus Genetics (IRD), had 9,511 shares sold on April 23, 2026 at $5.22 per share, generating proceeds of $49,647. The sale was recorded as an open market/private sale (S) but was executed automatically by the company to cover tax withholding from a restricted stock unit (RSU) vesting and settlement — not a discretionary trade by the CEO.

Key Details

• Transaction date and price: 2026-04-23, 9,511 shares at $5.22, total $49,647.
• Reason/footnote: Automatic sale to satisfy tax withholding obligations related to RSU vesting (Footnote F1).
• Shares owned after transaction: Not disclosed in the filing.
• Filing: Form 4 filed 2026-04-27; filing appears timely (filed within required business-day window).

Context Tax-withholding sales after RSU vesting are routine and do not necessarily indicate the insider’s view on the company’s prospects, since the sale is to cover taxes rather than a discretionary liquidation. For retail investors, purchases tend to be more informative about insider sentiment; this automatic sale should be viewed as a routine administrative action unless accompanied by additional discretionary trades.